Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05853900 · ClinicalTrials.gov registry record · NA
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
A NA study of Migraine and Headache, sponsored by Click Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 568
- Enrollment target
- 1
- Study location
NCT05853900 is a NA study of Migraine and Headache that has completed, run by Click Therapeutics. The registered enrollment target is 568 participants, above the 353-participant average among 102 other Migraine trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05853900, a NA study of Migraine and Headache, has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 568 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized study of two digital therapeutics for the prevention of episodic migraine
Conditions Studied
Interventions
- DEVICE ReMMi-D Digital Therapeutic
Study Locations (1)
New York
- Click Therapeutics - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 568 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2024-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05853900
The ClinicalTrials.gov registry entry for NCT05853900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 568 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 353-participant average among 102 other Migraine trials with a reported enrollment target (61% higher). The listed sponsor is Click Therapeutics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which ReMMi-D Digital Therapeutic is the first listed.
NCT05853900 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05853900 about?
NCT05853900 is a clinical study titled "Study of Two Digital Therapeutics for the Prevention of Episodic Migraine". Randomized study of two digital therapeutics for the prevention of episodic migraine
What is the current status of trial NCT05853900?
This trial is currently completed. It is a NA study. The enrollment target is 568 participants. The study started on 2023-03-28. Estimated completion is 2024-05-07.
What conditions does trial NCT05853900 study?
This clinical trial studies the following conditions: Migraine, Headache, Episodic Migraine, Headache, Migraine.
What interventions are being tested in trial NCT05853900?
The interventions under investigation include: ReMMi-D Digital Therapeutic (DEVICE).
Who is sponsoring clinical trial NCT05853900?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05853900 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.